Berliner Linke

Charité Berlin has treated a 19-year-old patient with the world's first approved CRISPR gene-editing therapy, marking the first time the treatment has been given in Germany since it received regulatory approval. The milestone is being celebrated as a landmark for German medicine, with links drawn to Emmanuelle Charpentier, the CRISPR pioneer whose work made such therapies possible.